So you have sameness issues now that are kind of initiated from the innovator brand side of the equation.
Editor's note · Context
Sarbanes discusses issues related to sameness in drug labeling.
Share & report
More from John Sarbanes
What that means is that for most other industries if an individual is harmed by their misconduct, they can file a claim...
Last year, as you know, Congress finally--finally, after many, many decades, really--took the historic step of standing up to Big Pharma and enacting policies that are already--we are seeing it--lowering healthcare costs for millions of…
If you concluded that putting some reasonable limits in place and trying to find a way to enforce them would lead some percentage of your users to leave TikTok and go somewhere else, is that something that you are prepared to accept?
It is clear that, at a minimum, taxpayer subsidies to that industry don't make any sense given the profits they are posting.





